Insider Monkey
Barclays Analyst Bullish on Iron Mountain Incorporated (IRM)
➖
AI Sentiment
Neutral
5/10
- Home
- GRFS
GRFS
Grifols S.A.
as of 12-04-2025 3:41pm EST
$8.92
+$0.13
+1.54%
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
Chart Type:
Time Range:
| Founded: | 1940 | Country: | Spain |
| Employees: | N/A | City: | N/A |
| Market Cap: | 5.9B | IPO Year: | 2006 |
| Target Price: | $10.30 | AVG Volume (30 days): | 667.0K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | Dividend Payout Frequency: | Annual | |
| EPS: | 0.64 | EPS Growth: | N/A |
| 52 Week Low/High: | $6.19 - $11.14 | Next Earning Date: | 01-01-0001 |
| Revenue: | $8,821,017,248 | Revenue Growth: | 7.31% |
| Revenue Growth (this year): | 5.46% | Revenue Growth (next year): | 5.60% |
AI-Powered GRFS Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 73.33%
73.33%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Grifols S.A. News
GRFS Breaking Stock News: Dive into GRFS Ticker-Specific Updates for Smart Investing
Compare GRFS vs Leading Stocks
See how GRFS stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "GRFS Grifols S.A. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.